Drug
PF 08046044 Sgn 35c
PF 08046044 Sgn 35c: highest development phase Phase 1, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| PF-08046044/SGN-35C NCT06254495 | Phase 1 | Hodgkin Disease |
Latest
No recent events.
Follow PF 08046044 Sgn 35c on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.